US 10973817
Pharmaceutical compounds
granted A61KA61K31/4155A61K31/454
Quick answer
US patent 10973817 (Pharmaceutical compounds) held by SENTINEL ONCOLOGY LIMITED expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTINEL ONCOLOGY LIMITED
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/4155, A61K31/454, A61K31/497, A61K31/5377